Related references
Note: Only part of the references are listed.First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
David Ruano et al.
MOLECULAR THERAPY (2020)
Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma
Flor Mendez et al.
CLINICAL CANCER RESEARCH (2020)
Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo
Ji Young Yoo et al.
NEURO-ONCOLOGY (2019)
Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models
Naiara Martinez-Velez et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease
J. Qi et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Preclinical therapeutic targets in diffuse midline glioma
Michael Hananja Meel et al.
DRUG RESISTANCE UPDATES (2019)
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Naiara Martinez-Velez et al.
NATURE COMMUNICATIONS (2019)
Safe and Effective Delivery of Antitumor Drug Using Mesenchymal Stem Cells Impregnated with Submicron Carriers
Alexander S. Timin et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma
Drew Spencer et al.
THERANOSTICS (2019)
Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting
Buddhadev Layek et al.
MOLECULAR CANCER THERAPEUTICS (2018)
microRNA-219 Reduces Viral Load and Pathologic Changes in Theiler's Virus-Induced Demyelinating Disease
Ana Lis Moyano et al.
MOLECULAR THERAPY (2018)
Therapy With Mesenchymal Stem Cells in Parkinson Disease: History and Perspectives
Daniel Mendes Filho et al.
NEUROLOGIST (2018)
Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy
Xiaoling Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
GlioVis data portal for visualization and analysis of brain tumor expression datasets
Robert L. Bowman et al.
NEURO-ONCOLOGY (2017)
Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
Tina Y. Huang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG)
Ho-Shin Gwak et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
A hydrogel matrix prolongs persistence and promotes specific localization of an oncolytic adenovirus in a tumor by restricting nonspecific shedding and an antiviral immune response
Bo-Kyeong Jung et al.
BIOMATERIALS (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature
Christopher Freese et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
Mahua Dey et al.
STEM CELL REPORTS (2016)
Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies
Laura Evgin et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response
Jianfeng Han et al.
CANCER RESEARCH (2015)
Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells
Katharina Hammer et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Novel delivery methods bypassing the blood-brain and blood-tumor barriers
Benjamin K. Hendricks et al.
NEUROSURGICAL FOCUS (2015)
Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition (vol 34, pg 1475, 2015)
M. Bonora et al.
ONCOGENE (2015)
Revisiting TP53 Mutations and Immunohistochemistry-A Comparative Study in 157 Diffuse Gliomas
Hirokazu Takami et al.
BRAIN PATHOLOGY (2015)
Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction
R. A. Morshed et al.
CANCER GENE THERAPY (2015)
Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes
Amanda M. Saratsis et al.
ACTA NEUROPATHOLOGICA (2014)
Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy
Jacob S. Young et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
Intranasal Delivery of Mesenchymal Stem Cells Significantly Extends Survival of Irradiated Mice with Experimental Brain Tumors
Irina V. Balyasnikova et al.
MOLECULAR THERAPY (2014)
Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
Barbara S. Paugh et al.
CANCER RESEARCH (2013)
A Preclinical Evaluation of Neural Stem CellBased Cell Carrier for Targeted Antiglioma Oncolytic Virotherapy
Atique U. Ahmed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Palliative Reirradiation for Progressive Diffuse Intrinsic Pontine Glioma
Hiral P. Fontanilla et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology
M. H. A. Jansen et al.
CANCER TREATMENT REVIEWS (2012)
Human adipose tissue-derived mesenchymal stem cells: Characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas
Seung Ah Choi et al.
EUROPEAN JOURNAL OF CANCER (2012)
Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment
Rintaro Hashizume et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma
Atique U. Ahmed et al.
MOLECULAR PHARMACEUTICS (2011)
Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease
Lusine Danielyan et al.
REJUVENATION RESEARCH (2011)
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
Barbara S. Paugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A human brainstem glioma xenograft model enabled for bioluminescence imaging
Rintaro Hashizume et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Bone Marrow Mesenchymal Stem Cells Loaded With an Oncolytic Adenovirus Suppress the Anti-adenoviral Immune Response in the Cotton Rat Model
Atique U. Ahmed et al.
MOLECULAR THERAPY (2010)
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats
A. M. Sonabend et al.
CANCER GENE THERAPY (2009)
Human Bone Marrow-Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Delta 24-RGD to Human Gliomas
Raymund L. Yong et al.
CANCER RESEARCH (2009)
Intranasal delivery of cells to the brain
Lusine Danielyan et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2009)
New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163
Rintaro Hashizume et al.
NEURO-ONCOLOGY (2008)
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma
Adam M. Sonabend et al.
STEM CELLS (2008)
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy
Kazuhiko Kurozumi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2007)
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma
Ilya V. Ulasov et al.
HUMAN GENE THERAPY (2007)
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
Giulia Fulci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma
WJ van Houdt et al.
JOURNAL OF NEUROSURGERY (2006)
Share Paper
